Vladimir Vorobyev (V I Vorobyev)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

Terapevticheskii arkhiv

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tahla Munir, Carol Moreno, Carolyn Owen, George Follows, Ohad Benjamini, Ann Janssens, Mark-David Levin, Anders Osterborg, Tadeusz Robak, Martin Simkovic, Don Stevens, Sergey Voloshin, Vladimir Vorobyev, Munci Yagci, Loic Ysebaert, Keqin Qi, Qianya Qi, Lori Parisi, Srimathi Srinivasan, Natasha Schuier, Kurt Baeten, Angela Howes, Donne Bennett Caces, Carsten Utoft Niemann, Arnon P Kater
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
V A Zherebtsova, Vladimir Vorobyev, E G Gemdzhian, M A Ulyanova, M V Chernikov, V L Ivanova, Olga Vinogradova, Vadim V Ptushkin
[Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience]. Terapevticheskii arkhiv 93 (7) (2021)
Vladimir Vorobyev, E G Gemdzhian, Liudmila V Fedorova, N B Mikhailova, R K Ilyasov, L P Kaleikina, O S Trubyakova, Kamil D Kaplanov, E V Melnichenko, E V Martynova, E P Yakovleva, O Y Li, E V Tarasenko, E P Chumakova, N B Bulieva, E S Nesterova, O V Margolin, V A Zherebtsova, L S Butaev, Vadim V Ptushkin
[Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice]. Terapevticheskii arkhiv 93 (7) (2021)
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Christian Recher, Andre C Schuh, Michael J Thirman, Jacqueline S Garcia, Courtney D D DiNardo, Vladimir Vorobyev, Nicola Stefano Fracchiolla, Su-Peng Yeh, Jun Ho Jang, Muhit Özcan, Kazuhito Yamamoto, Arpad Illes, Ying Zhou, Monique Dail, Brenda Chyla, Jalaja Potluri, Hartmut Döhner
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2021)